{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:28:40Z","timestamp":1787376520812,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA260223"],"award-info":[{"award-number":["R37CA260223"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA298971"],"award-info":[{"award-number":["P01CA298971"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA278961"],"award-info":[{"award-number":["R01CA278961"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA277018"],"award-info":[{"award-number":["R21CA277018"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.celbio.2026.100558","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:20:01Z","timestamp":1786634401000},"page":"100558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomaterial-enabled in vivo T cell engineering: A new paradigm for cell therapy"],"prefix":"10.1016","author":[{"given":"Sharda","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Abbey","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2963-3293","authenticated-orcid":false,"given":"Yevgeny","family":"Brudno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2026.100558_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/OP.22.00315","article-title":"Chimeric antigen receptor T-cell therapies: Barriers and solutions to access","volume":"18","author":"Mikhael","year":"2022","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.celbio.2026.100558_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtct.2024.04.017","article-title":"Chimeric antigen receptor T-cell access in patients with relapsed\/refractory large B-cell lymphoma: Association of access with social determinants of health and travel time to treatment centers","volume":"30","author":"Ahmed","year":"2024","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celbio.2026.100558_bib6","doi-asserted-by":"crossref","first-page":"876339","DOI":"10.3389\/fimmu.2022.876339","article-title":"Impact of manufacturing procedures on CAR T cell functionality","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100558_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006292","article-title":"Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering","volume":"11","author":"Michels","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celbio.2026.100558_bib8","first-page":"5702","article-title":"Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.celbio.2026.100558_bib9","article-title":"In vivo production of CAR T cell: Opportunities and challenges","volume":"12","author":"Song","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.celbio.2026.100558_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2018.04.012","article-title":"Modulation of immune responses in lentiviral vector-mediated gene transfer","volume":"342","author":"Annoni","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.celbio.2026.100558_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100558_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/btm2.10063","article-title":"Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine","volume":"2","author":"Andorko","year":"2017","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acs.accounts.0c00341","article-title":"Biomaterials as Local Niches for Immunomodulation","volume":"53","author":"Adu-Berchie","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.celbio.2026.100558_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121872","article-title":"Injectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice","volume":"291","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8264","article-title":"Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors","volume":"8","author":"Grosskopf","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celbio.2026.100558_bib16","article-title":"Charged substrate treatment enhances T cell mediated cancer immunotherapy","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100558_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphy.2019.00045","article-title":"T-cell mechanobiology: Force sensation, potentiation, and translation","volume":"7","author":"Harrison","year":"2019","journal-title":"Front. Phys."},{"key":"10.1016\/j.celbio.2026.100558_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120797","article-title":"Biphasic response of T cell activation to substrate stiffness","volume":"273","author":"Yuan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121928","article-title":"Substrate stiffness enhances human regulatory T cell induction and metabolism","volume":"292","author":"Shi","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2024.04.040","article-title":"Biomaterial-based scaffolds for direct in situ programming of tumor-infiltrating T lymphocytes","volume":"370","author":"Inamdar","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100558_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501529","article-title":"In vivo accumulation of regulatory T cells using eliglustat-loaded cryogels","volume":"14","author":"Vitner","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41551-022-00977-0","article-title":"Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds","volume":"7","author":"Majedi","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celbio.2026.100558_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122580","article-title":"Implantable CAR T cell factories enhance solid tumor treatment","volume":"308","author":"Pandit","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib24","doi-asserted-by":"crossref","unstructured":"Pandit, S., Agarwalla, P., Song, F., Jansson, A., Dotti, G., and Brudno, Y. (2023) Implantable Car T Cell Factories Enhance Solid Tumor Treatment. https:\/\/doi.org\/10.2139\/ssrn.4648848.","DOI":"10.2139\/ssrn.4648848"},{"key":"10.1016\/j.celbio.2026.100558_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae018","article-title":"Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor","volume":"11","author":"Liao","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.celbio.2026.100558_bib26","article-title":"Injectable supramolecular hydrogels for in situ programming of car-T cells toward solid tumor immunotherapy","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib27","article-title":"Implantable biomaterials for cancer immunotherapies","volume":"35","author":"Pechnikova","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature08604","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100558_bib29","article-title":"An injectable hydrogel to modulate T cells for cancer immunotherapy","volume":"18","author":"Zhang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.celbio.2026.100558_bib30","article-title":"Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100558_bib31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.cels.2024.11.007","article-title":"Emerging approaches for T cell-stimulating platform development","volume":"15","author":"Ariail","year":"2024","journal-title":"Cell Syst."},{"key":"10.1016\/j.celbio.2026.100558_bib32","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41587-022-01245-x","article-title":"Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells","volume":"40","author":"Agarwalla","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100558_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121972","article-title":"T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy","volume":"293","author":"Bhatta","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib34","article-title":"In vivo stimulation of therapeutic antigen-specific T cells in an artificial lymph node matrix","volume":"36","author":"Livingston","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41551-024-01216-4","article-title":"Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells","volume":"9","author":"Zhang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celbio.2026.100558_bib36","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100558_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.scib.2023.11.055","article-title":"In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles","volume":"69","author":"Zhao","year":"2024","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.celbio.2026.100558_bib39","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100558_bib40","article-title":"Critical quality attributes of lipid nanoparticles and in vivo fate","volume":"20","author":"Di","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.celbio.2026.100558_bib41","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib42","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib43","series-title":"ACR Meeting Abstracts","article-title":"A Novel Product Candidate (CPTX2309) for In Vivo mRNA Engineering of Anti-CD19 CAR T Cells Utilizing Novel CD8-Targeted Lipid Nanoparticles","author":"Hunter","year":"2024"},{"key":"10.1016\/j.celbio.2026.100558_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011759","article-title":"T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles","volume":"13","author":"Bimbo","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celbio.2026.100558_bib45","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"In vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100558_bib61","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-4106","article-title":"In Vivo generation of anti-CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases","volume":"146","author":"Pasackow","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.celbio.2026.100558_bib62","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.ymthe.2026.02.020","article-title":"Reprogramming CD22 CAR-T cells in vivo Using CD8-Targeted mRNA-LNPs to Treat Hematological Malignancies","volume":"34","author":"Lemgart","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib63","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-104","article-title":"In Vivo pan CAR therapy utilizing circular RNA for treatment of autoimmune diseases","volume":"146","author":"Soto","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.celbio.2026.100558_bib64","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-208176","article-title":"Targeted lipid nanoparticle delivery of an RNA Gene Writer in vivo enables generation of CAR-T cells in a humanized mouse model","volume":"144","author":"Rodriguez","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.celbio.2026.100558_bib65","series-title":"Regular and Young Investigator Award Abstracts","article-title":"1098 In vivo VLP-based engineering generates multi-lineage CAR-immune cells that mediate potent and durable anti-tumor activity","author":"Decker","year":"2024"},{"key":"10.1016\/j.celbio.2026.100558_bib66","article-title":"In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity","volume":"33","author":"Nyberg","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib67","series-title":"Molecular Therapy","article-title":"Optimizing VHH ligand density in T cell-targeted LNPs: an inverted U-shaped relationship for effective in vivo CAR T cell generation","author":"Hashiba","year":"2025"},{"key":"10.1016\/j.celbio.2026.100558_bib68","article-title":"In vivo Transient Programming of T cells with SAIL\u2019s Targeted Nanoparticles Encapsulating eRNA-encoded hCD19 CAR Achieves Deep Depletion of B cells in blood and lymphoid tissues in a B-cell Repopulating Humanized Mouse Model","volume":"33","author":"Beaulieu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celbio.2026.100558_bib69","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-103","article-title":"Precision In Vivo CAR-T generation via CLAMP-enabled mRNA delivery: Toward scalable and translatable cell therapy","volume":"146","author":"Sun","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.celbio.2026.100558_bib70","unstructured":"OrbitaltX. (2025). Orbital Therapeutics Presents Non-Human Primate Data for In Vivo CAR-T Therapy with Potential Best-in-Class Profile for Autoimmune Disease. https:\/\/www.orbitaltx.com\/orbital-therapeutics-presents-non-human-primate-data-for-in-vivo-car-t-therapy-with-potential-best-in-class-profile-for-autoimmune-disease\/."},{"key":"10.1016\/j.celbio.2026.100558_bib71","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1158\/1538-7445.AM2025-6401","article-title":"Abstract 6401: In vivo mRNA CAR-T cell engineering using peptide based targeted nanoparticles","volume":"85","author":"Divita","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.celbio.2026.100558_bib72","series-title":"Regular and Young Investigator Award Abstracts","first-page":"A1236","article-title":"1114 In vivo CAR delivery as supercoiled DNA with polyasparagine nanoparticles","author":"Lee","year":"2024"},{"key":"10.1016\/j.celbio.2026.100558_bib73","series-title":"Arthritis Rheumatol.","article-title":"In Vivo Generation of anti-CD19 CAR T Cells Utilizing Circular RNA Encapsulated in Targeted Lipid Nanoparticles","author":"Pan","year":"2025"},{"key":"10.1016\/j.celbio.2026.100558_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.actbio.2020.06.004","article-title":"Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction","volume":"112","author":"Rhodes","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.celbio.2026.100558_bib48","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1111\/ajt.16748","article-title":"Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection","volume":"21","author":"Zhou","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.celbio.2026.100558_bib49","article-title":"Fabrication of active targeting lipid nanoparticles: Challenges and perspectives","volume":"16","author":"Menon","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.celbio.2026.100558_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw4744","article-title":"Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter","volume":"12","author":"Eskandari","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib51","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2025.94907359","article-title":"Hyaluronidase nanogel-armed CAR-T cell for synergistically reducing tumor extracellular matrix and improving efficacy against solid tumors","volume":"18","author":"Zhao","year":"2025","journal-title":"Nano Res."},{"key":"10.1016\/j.celbio.2026.100558_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jbm.a.37442","article-title":"Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents","volume":"111","author":"Marshall","year":"2023","journal-title":"J. Biomed. Mater. Res., A"},{"key":"10.1016\/j.celbio.2026.100558_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nbt.3462","article-title":"Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates","volume":"34","author":"Vegas","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100558_bib54","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41563-025-02383-8","article-title":"Designing around immune memory to counter PEG immunogenicity","volume":"24","author":"Chaudhary","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.celbio.2026.100558_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202414724","article-title":"Engineering the immune response to biomaterials","volume":"12","author":"Salehi Moghaddam","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celbio.2026.100558_bib56","series-title":"Immunomodulatory Biomaterials","first-page":"251","article-title":"Machine learning and mechanistic computational modeling of inflammation as tools for designing immunomodulatory biomaterials","author":"An","year":"2021"},{"key":"10.1016\/j.celbio.2026.100558_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1544393","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.celbio.2026.100558_bib58","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acs.jmedchem.5c03844","article-title":"Interleukin 2-based cancer immunotherapies: The discovery of next-generation antibody-cytokine bispecific antibody drug","volume":"69","author":"Zhao","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celbio.2026.100558_bib59","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100558_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.trecan.2026.01.007","article-title":"In vivo CAR T cell engineering: design principles and open questions","volume":"12","author":"Aalipour","year":"2026","journal-title":"Trends Cancer"},{"key":"10.1016\/j.celbio.2026.100558_bib74","first-page":"3","article-title":"Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy","volume":"11","author":"Dandia","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.celbio.2026.100558_bib75","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1021\/acsami.2c10727","article-title":"Customized multifunctional peptide hydrogel scaffolds for CAR-T-cell rapid proliferation and solid tumor immunotherapy","volume":"14","author":"Jie","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305056232600214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305056232600214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:06:23Z","timestamp":1787375183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S305056232600214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":75,"alternative-id":["S305056232600214X"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100558","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial-enabled in vivo T cell engineering: A new paradigm for cell therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100558"}}